Schedule 13G ownership disclosure

Castle Biosciences Inc

Common Stock · CUSIP: 14843C105

Event date: 2025-12-31

Filing-level shares
1,143,799.00
Percent of class
3.9%
  • Dimensional Fund Advisors LP

    Shares: 1,143,799.00 · Class: 3.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000354204-26-000274
Form type
SCHEDULE 13G/A
Filer
CASTLE BIOSCIENCES INC
CIK
CIK 1447362
Filed
Jan 21, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub